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Abstract
Background: Nuclear receptors are hormone-regulated transcription factors whose signaling
controls numerous aspects of development and physiology. Many receptors recognize DNA
hormone response elements formed by direct repeats of RGKTCA motifs separated by 1 to 5 bp
(DR1-DR5). Although many known such response elements are conserved in the mouse and
human genomes, it is unclear to which extent transcriptional regulation by nuclear receptors has
evolved specifically in primates.
Results: We have mapped the positions of all consensus DR-type hormone response elements in
the human genome, and found that DR2 motifs, recognized by retinoic acid receptors (RARs), are
heavily overrepresented (108,582 elements). 90% of these are present in Alu repeats, which also
contain lesser numbers of other consensus DRs, including 50% of consensus DR4 motifs. Few DR2s
are in potentially mobile AluY elements and the vast majority are also present in chimp and
macaque. 95.5% of Alu-DR2s are distributed throughout subclasses of AluS repeats, and arose
largely through deamination of a methylated CpG dinucleotide in a non-consensus motif present in
AluS sequences. We find that Alu-DR2 motifs are located adjacent to numerous known retinoic
acid target genes, and show by chromatin immunoprecipitation assays in squamous carcinoma cells
that several of these elements recruit RARs in vivo. These findings are supported by ChIP-on-chip
data from retinoic acid-treated HL60 cells revealing RAR binding to several Alu-DR2 motifs.
Conclusion: These data provide strong support for the notion that Alu-mediated expansion of
DR elements contributed to the evolution of gene regulation by RARs and other nuclear receptors
in primates and humans.
Background
Alu repeats are SINEs (Short INterspersed Elements)
whose original insertion in genomic sequences appears to
have occurred shortly after the dawn of the primate line-
age. While most SINEs arose from tRNA genes, Alu ele-
ments are derived from the 7SL RNA gene, which encodes
a component of the protein signal recognition complex.
The structure of modern Alu sequences arose from a
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duplication of primordial elements, which were approxi-
mately 200 bp in length and composed of an RNA
polymerase III promoter at one extremity and a polyA tail
at the other. Dimeric Alu elements expanded extensively
throughout primate genomes as a result of a parasitic rela-
tionship with the transposition machinery encoded by L1
retrotransposons, which are LINEs (Long INterspersed
Elements) [1,2], and today occupy ~10% of the human
genome.
Several lines of evidence indicate that a variety of events
associated with Alu transposition, recombination and
expansion have contributed to genome evolution and to
altering gene expression by several mechanisms. Because
of their high CpG content and the tendency of CpG dinu-
cleotides to mutate, and because of their prevalence, Alu
repeats contain a substantial percentage of the single
nucleotide polymorphisms in the human genome [1].
Their polyA tails act to seed microsatellite formation and
expansion [3]. Moreover, Alu transposition has been pro-
posed to underlie the expansion of segmental duplica-
tions that comprise approximately 5% of the human
genome [4]. Conservative estimates suggest that 0.3–0.5%
of human genetic disorders arise from mobile element
insertion or from element-driven recombination events
[5,6]. There is also evidence that Alu repeats inserted in an
antisense orientation to gene transcripts can introduce
alternative splicing sites [7,8], and that insertion of Alu
sequences may alter epigenetic regulation of gene expres-
sion [9].
In addition to the above, increasing evidence suggests that
Alu repeats are a source of elements that regulate tran-
scriptional initiation by RNA polymerase II [10].
We have been interested in genome-wide mapping of hor-
mone response elements in the promoter-proximal
regions of human genes [11,12] to study their evolution-
ary conservation in the vicinity of genes, and their accessi-
bility to cognate members of the nuclear receptor family.
Nuclear receptors are the primary targets of a range of
lipophilic signaling molecules such as steroid and thyroid
hormones, vitamin D, retinoids, specific prostaglandins
and cholesterol metabolites that regulate many aspects of
physiology and metabolism, as well as embryonic devel-
opment [13]. They directly regulate gene transcription by
ligand-dependent recruitment of so-called coregulatory
proteins that carry out the histone modifications, chroma-
tin remodeling and binding of RNA polymerase II and
ancillary factors necessary for initiation of transcription
[13,14].
Nuclear receptors are composed of a series of domains,
with the DNA binding and ligand binding domains being
the most highly conserved. Most nuclear receptors func-
tion as homo- or heterodimers, and many receptor DNA
binding domains recognize variants of consensus
RGKTCA motifs arranged as either direct or inverted
repeats[15]. Many non-steroid receptors recognize direct
repeats in the form of heterodimers with members of the
retinoid × receptor (RXR) family. For example, retinoic
acid receptors (RARs) heterodimerized with RXRs specifi-
cally recognize retinoic acid response elements (RAREs) as
RGKTCA direct repeats separated by 1, 2 or 5 bp (DR1,
DR2 or DR5 motifs), whereas heterodimerized receptors
for vitamin D (VDR) and thyroid hormone (TR) recognize
DR3 and DR4 elements, respectively.
Evidence is accumulating that Alu repeats constitute a sig-
nificant source of hormone response elements [16]. Nota-
bly, a motif, AGGTCAnnAGTTCG, found within most
subclasses of AluS sequences, corresponds to a non-con-
sensus DR2 element recognized by RARs, and has been
shown to function as a RARE [17]. Signaling through
RARs is of particular interest because retinoids control
many aspects of embryonic development in a wide variety
of organisms [13,18,19].
Here, we used a genome-wide screen to map DR-type hor-
mone response elements in the human genome, and
found that consensus DR2 elements are massively over-
represented relative to DR1 and DR5 RAREs and DRs rec-
ognized by other nuclear receptors, due to the presence of
consensus DR2 motifs in >100,000 Alu repeats. The vast
majority of these correspond to AluS sequences, which
drove the Alu element expansion in primate that started
35–40 Myr ago. We also show that these "Alu-DR2" ele-
ments are present in retinoic acid regulated genes and
bind RARs in vivo. Taken together, our data provide
strong support for the notion that Alu-mediated expan-
sion of DR elements contributed to the evolution of gene
regulation by RARs and other nuclear receptors in pri-
mates and humans.
Results
Mapping DR-type hormone response elements in the 
human and mouse genomes
A number of nuclear receptors recognize direct repeats of
RGKTCA motifs spaced between 1 and 5 nucleotides as
response elements, and individual receptors distinguish
between DR elements based on inter-repeat spacings and
subtle differences in motif sequence [15]. Sequencing of
entire genomes has opened the way to mapping DNA
response elements for nuclear hormone receptors on a
genome-wide scale [11,12]. Given that mice have been
used extensively as genetic models to study nuclear recep-
tor signaling (e.g. [19]), we compared the frequency and
distribution of consensus direct repeat response elements
[RGKTCAniRGKTCA, i = 1 to 5] both in the mouse and
human genomes (Table 1). Although the frequency ofBMC Genomics 2007, 8:23 http://www.biomedcentral.com/1471-2164/8/23
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these motifs should be comparable in random DNA
sequences, our screen revealed that DR2 elements are
about 10-fold more frequent than other DR sequences in
the human genome, and are about 4-fold more common
than in the mouse genome (108,582 vs 26,717). In addi-
tion, DR1 and DR4 elements occur more frequently than
DR3 or DR5 elements (about 2-fold). To investigate the
varying frequencies of different DR elements in the
human and mouse genomes, we examined the propor-
tions of each of these motifs found in transposable ele-
ments (TEs, Table 1). The vast majority of human DR2
motifs map within SINEs, in particular in Alu repeats
(102,359/102,564 elements, see Figure 1 and Table 1),
while approximately 50% of DR2 elements in the mouse
(13,356) are found in retroviral LTRs, which only account
for 1064 of the human elements (Table 1). DR4 motifs
were also significantly associated within SINEs in the
human genome, whereas DR1 motifs in TEs are found
mostly in LINEs (Table 1). The frequencies of DR ele-
ments outside TEs is relatively similar, indicating that
incorporation of DR elements within SINEs, LINEs or
LTRs is the main cause for their variable distributions.
Over 100,000 consensus DR elements are present in Alu 
repeats
To assess whether the large over-representation of DR2s in
SINEs reflects amplification of a specific sequence, we cal-
culated the frequencies of all motifs corresponding to the
DR2 consensus. Of the 102,359 consensus DR2 elements
located in Alu repeats, 92,686 corresponded to the
sequence AGGTCAnnAGTTCA, and of these, AGGTCAg-
gAGTTCA accounted for 82,319 occurrences, along with
9,877 copies with only one variation in the spacer nucle-
otides (data not shown). Other consensus DR2 elements
containing one variation in the repeated motifs were
much less frequent (less than 3,000 copies each for the
single variations at the R and K positions, as calculated
from the percentages in DR2 elements listed in Table 2).
Consensus DR1 or DR3 motifs resulting from removal or
addition of one nucleotide from the highly represented
DR2 sequence were even more infrequent in Alu repeats
(less than 0.2% or about 200 copies, Table 2, line 2).
The 102,359 DR2 elements, which are RAR target
sequences, are by far the most frequent consensus DR
motif present in Alu repeats (93.4%, Fig. 1), followed by
DR4 elements, recognized specifically by TRs (5.7% or
6198 occurrences, Fig. 1). It is noteworthy that the 6198
Alu-DR4 elements represent ~50% of the total consensus
DR4 elements in the genome (Fig. 1). Moreover, unlike in
the DR2 consensus, RGGTCA motifs are found predomi-
nantly in the 3' repeat of the Alu DR4 sequences (Table 2,
DR4 column). This position is bound by the TR when
RXR-TR heterodimers bind to DR4 motifs. Since the TR
has weak affinity for RGTTCA but recognizes RGGTCA
motifs [20], these DR4 elements represent optimal TR
binding sites.
The vast majority of Alu-DR elements are present in AluS 
sequences
Further analysis of human DR2-Alu elements revealed
that their 5' ends are tightly clustered around positions
66–68 of the Alu repeat (Fig. 2). DR1 and DR3 elements
showed largely similar distributions. In contrast, the 5'
ends DR4 elements were found predominantly at position
58 of the repeat (Fig. 2). While DR5 elements were some-
what more widely distributed, most motifs started at posi-
tions 58, 66 or 68. The results reveal that DR2 and DR4
elements originated from partially overlapping sequences,
where the 5' half-site of the consensus DR2 element corre-
sponds to the 3' half-site of the DR4 motif (see below).
The vast majority of consensus DR2 elements (97,779 or
95.5%; Fig. 3A) are present in AluS sequences, which rep-
resent just under 56% of total Alu sequences in the human
genome. The overrepresentation of DR elements in AluS
sequences, which largely drove the Alu repeat expansion
35–40 Myr ago [1,2,4], indicates that the majority of the
consensus Alu-DR2 sequences (and related DR elements)
present in the human genome multiplied through pri-
mate genomes during this AluS expansion. Consensus
DR4 elements are similarly distributed primarily in AluS
sequences (Fig. 3A). In contrast, consensus DR2 elements
are markedly underrepresented in older AluJ and younger
AluY sequences (2.3% and 1.7%, respectively; Fig. 3A). Of
the 1.7% of DR2 motifs (1740 in total) present in poten-
tially mobile AluY elements, only 41 motifs were not
found to be present in the chimp and rhesus macaque
genomes [see Additional file 1], indicating that more
recent AluY-mediated transposition was not a major driv-
Table 1: Consensus RGKTCA direct repeats found in the human and mouse genomes.
Total outside transposable elements in SINEs in LINEs in LTRs
Human Mouse Human Mouse Human Mouse Human Mouse Human Mouse
DR1 11230 16250 5950 9741 687 3679 3633 788 960 2042
DR2 108582 26717 4186 5623 102564 7157 768 581 1064 13356
DR3 6707 6336 3935 4192 997 571 936 605 839 968
DR4 12376 8893 4397 5549 6602 638 621 457 756 2249
DR5 5786 8846 4337 5338 430 1059 552 1073 467 1376BMC Genomics 2007, 8:23 http://www.biomedcentral.com/1471-2164/8/23
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ing force in shaping retinoid-regulated gene expression in
the human genome.
Consensus Alu-DR2 elements arose predominantly via 
deamination of a methylated CpG dinucleotide
The distribution and frequency of DR2 elements in Alu
sequences can be explained by the fact that the consensus
DR2 RARE differs from the consensus sequence of several
AluS subfamilies by a single G to A substitution in the 3'-
most nucleotide of the DR2 repeat, whereas generation of
an RARE consensus from Alu J or Y sequences would
require multiple substitutions (Fig. 3B). Similarly, a single
A to G or T substitution in the third position of the
upstream GGATCA motif in AluS subfamilies Sx, Sq and
Sp would generate a consensus DR4 element. Note how-
ever that although two different single mutations can lead
to formation of a consensus DR4 versus one single
replacement leading to a consensus DR2, the rate of con-
version to a consensus DR2 is far superior to that to a DR4
element in all Alu subclasses.
It is noteworthy that generation of the DR2 RARE consen-
sus could occur through deamination of a methylated C
residue in the CpG dinucleotide of the AluS consensus,
converting it to a T on the complementary strand of the
direct repeat. A comparison of the frequencies of all four
possible CpN dinucleotides in AGGTCAnnAGTTCN
motifs present in AluS sequences indicates that CpA
occurs far more frequently than CpT or CpC (Fig. 3C).
Similarly, the conversion to T of the C residue of the CpG
on the sense strand occurred far more frequently than
other substitutions (Fig. 3C). Collectively, these data sup-
port the notion that the CpA dinucleotide in the DR2 ele-
ment arose predominantly via a deamination-driven
mechanism rather than by random base substitutions.
The data are also consistent with other observations of
high rates of CpG methylation [21] and of CpG dinucle-
otide decay generally in Alu repeats [22,23]. Further, the
rate of conversion to consensus DR2s was similar in differ-
ent subclasses of AluS elements differing by only one
nucleotide (about 15–20% except for the AluSg1, a minor
subfamily of AluSg [24], for which the rate of conversion
is about 60%, Fig. 3B), suggesting generation of DR2s via
the same methylation/deamination mechanism through-
out evolution of the family. In addition, it is worth noting
that the conversion to a perfect DR2 from the consensus
Consensus DR1 to DR5 motifs embedded within Alu ele- ments in the human genome Figure 1
Consensus DR1 to DR5 motifs embedded within Alu 
elements in the human genome. The numbers below 
each DR correspond to the total number of repeats in Alu 
elements/total number of repeats in the genome.
DR5          
(221/5786)
DR4      
(6198/12376)
DR3          
(343/6707)
DR2 
(102359/108582)
DR1        
(423/11230)
0 20 40 60 80 100%
in Alu not in Alu
Table 2: RGKTCA direct repeats found in Alu elements.
DR sequence # in Alu % in DR1 % in DR2 % in DR3 % in DR4 % in DR5
AGGTCA AGGTCA 2888 0.90 49.90 0.73 47.64 0.83
AGGTCA AGTTCA 93067 0.19 99.59 0.11 0.06 0.05
AGGTCA GGGTCA 78 23.08 39.74 6.41 25.64 5.13
AGGTCA GGTTCA 2212 2.40 96.11 1.04 0.31 0.14
AGTTCA AGGTCA 524 0.95 46.95 1.72 49.62 0.76
AGTTCA AGTTCA 2389 1.21 95.10 1.80 0.63 1.26
AGTTCA GGGTCA 10 20.00 60.00 0.00 20.00 0.00
AGTTCA GGTTCA 137 12.41 78.10 3.65 2.19 3.65
GGGTCA AGGTCA 5244 0.08 29.67 0.27 69.68 0.30
GGGTCA AGTTCA 1285 0.70 91.91 0.47 6.69 0.23
GGGTCA GGGTCA 94 1.06 27.66 9.57 54.26 7.45
GGGTCA GGTTCA 44 11.36 68.18 2.27 13.64 4.55
GGTTCA AGGTCA 1096 0.18 42.43 0.27 55.84 1.28
GGTTCA AGTTCA 197 5.58 41.11 27.92 13.71 11.68
GGTTCA GGGTCA 21 9.52 61.91 0.00 19.05 9.52
GGTTCA GGTTCA 258 24.03 35.66 18.61 7.75 13.95
RGKTCA RGKTCA 109544 0.39 93.44 0.31 5.66 0.20BMC Genomics 2007, 8:23 http://www.biomedcentral.com/1471-2164/8/23
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AluS sequence, while introducing a change in the
sequence of the box B of the RNA polIII promoter, occurs
without altering its consensus (GWTCRANNC), suggest-
ing that Alu elements containing perfect DR2 may still be
mobile [25]. In a recent paper Price et al. defined over 200
AluS subfamilies [26], seven of which contain consensus
DR2 elements. One of these, AluSg_14 shares the presence
of the consensus RARE DR2 with three subfamilies [see
Additional file 4]. These AluS subfamilies are likely exam-
ples of DR2 elements amplified by transposition instead
of spontaneous mutation of a CpG.
Distribution of Alu-DR2 elements relative to the 5'ends of 
human genes
Generation of consensus DR2 in Alu elements via a mech-
anism implicating methylation of CpG dinucleotides,
which is associated with transcriptional silencing, raises
the question of whether these motifs can be recognized by
RARs as functional binding sites. To investigate whether
these elements could contribute to gene regulation, we
first characterized the distribution of repeats containing
DR2 elements relative to the 5' ends of human genes (Fig.
4). The distribution of Alu-DR2 differed from that of Alu
repeats (χ2 test, p-value = 2.84E-19), with a sharper reduc-
tion in the number of elements between -2 and +2 kb of
transcriptional start sites. We note that there was a 20–
30% further relative reduction in elements containing
DR2 motifs within 1 kb of known 5' ends of genes com-
pared to the general distribution of Alu elements, sugges-
tive of a selection pressure against the presence of
promoter-proximal Alu-DR2 sequences. However, RAREs
are known to function as enhancer elements at distances
up to 10–20 kb. Our mapping studies revealed over
18,000 Alu-DR2 elements lying within -10 kb and +10 kb
of the 5'ends of >10,000 genes, [see Additional file 2], rep-
resenting a substantial proportion of human genes.
Association of RARs with Alu-DR2 elements in vivo
It is highly likely that most of the genes with proximal
Alu-DR2 elements are not implicated in RAR-dependent
gene regulation in a given cell type, with access to the sites
being potentially limited by chromatin structure or bind-
ing of other proteins. For example, chromatin immuno-
precipitation studies followed by microarray analysis
(ChIP-on-chip) of genes regulated by related estrogen
receptors in estrogen-sensitive breast carcinoma cells have
suggested that only a minority of potential high affinity
estrogen response elements of a given chromosome are
accessible to receptors [27]. Moreover, as mentioned
above, Alu repeat sequences are highly susceptible to
methylation [21], which correlates with a closed chroma-
tin structure and transcriptional silencing. However, 363
Alu-DR2 were found near 193 known retinoic acid target
genes [see Additional file 2], suggesting that some Alu-
DR2 elements can drive retinoid-regulated gene expres-
sion. We therefore tested the accessibility of several of
these Alu-DR2 sequences to RARs by chromatin immuno-
precipitation (ChIP) assay. We chose multiple elements
present in the vicinity of 5 genes known to be RA-respon-
Positions of DR motifs within Alu sequences in the human  genome Figure 2
Positions of DR motifs within Alu sequences in the 
human genome. For clarity, only every 10th position is 
indicated, along with positions 58, 66 and 68. The positions 
indicated correspond to the 5'nucleotide of the 5'half site. 
Note the differences in scales of the ordinates.
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Consensus DR2 and DR4 elements are found predominantly in AluS sequences Figure 3
Consensus DR2 and DR4 elements are found predominantly in AluS sequences. (A) Distribution of consensus DR2 
and DR4 elements within AluJ, S and Y families in the human genome. (B) Consensus sequences of AluJ, AluY and AluS sub-
families within the region containing the DR4 and DR2 element, and frequency of consensus DR2 RARE sequences within each 
subfamily. The position of box B of the polymerase III promoter is provided above. The sequences of the DR4 and DR2 con-
sensus motifs are provided below. (C) Nucleotide substitution frequencies of the CpG dinucleotide present within AGGT-
CAnnAGGTCG motifs in AluS sequences.
other
AluY
A
% DR4 
in Alu
% Alu in 
genome
% DR2 
in Alu
100.00 6198 100.00 102359 100.00
0.45 28 0.47 481 6.94
0.37 23 1.70 1740 12.67
96.76 5997 95.53 97779 55.91 AluS
2.42 150 2.30 2359 24.48 AluJ
# DR4 # DR2
Alu 
Family
RGKTCANNNNRGKTCA
RGKTCANNRGKTCA
** *** ***** *  ***  *  *** **  * *     
GGCGGGCGGATCAC--GAGGTCAGGAGATCGAGACCATCC
GGCGGGCGGATCAC--GAGGTCAAGAGATCGAGACCATCC
GGCGGGCGGATCACCTGAGGTCGGGAGTTCGAGACCAGCC
GGCGGGCGGATCACCTGAGGTCAGGAGTTCGAGACCAGCC
GGCGGGCGGATCAC--GAGGTCAGGAGTTCGAGACCAGCC
GGCGGGCGGATCAC--GAGGTCAGGAGTTCGAGACCAGCC
GGCGGGCGGATCACCTGAGGTCAGGAGTTCGAGACCAGCC
GGCGGGAGGATCACTTGAGCCCAGGAGTTCGAGACCAGCC
GGTGGGAGGATCGCTTGAGTCCAGGAGTTCTGGGCTGTAG
B-BOX GWTCRANNC
AluY
AluSc
AluSp
AluSq
AluSg1
AluSg
AluSx
AluJb
7SLRNA
1.20
1.41
6.44
18.97
59.81
20.67
16.18
0.01
0.01
0.46
1.35
0.09
0.01
1.29
0.06 0.74
% with
DR4
% with
DR2
DR2
DR4
B
6025 302332 308357 Total
578 758 1336 AGGTCA NN AGTTtt
562 79882 80444 AGGTCA NN AGTTtg
406 1219 1625 AGGTCA NN AGTTtc
442 3173 3615 AGGTCA NN AGTTtA
310 80 390 AGGTCA NN AGTTgt
357 6627 6984 AGGTCA NN AGTTgg
248 126 374 AGGTCA NN AGTTgc
333 1588 1921 AGGTCA NN AGTTgA
537 2377 2914 AGGTCA NN AGTTCt
79 102578 102657 AGGTCA NN AGTTCg
310 7352 7662 AGGTCA NN AGTTCc
592 92686 93278 AGGTCA NN AGTTCA
334 33 367 AGGTCA NN AGTTat
299 2906 3205 AGGTCA NN AGTTag
250 153 403 AGGTCA NN AGTTac
388 794 1182 AGGTCA NN AGTTaA
outside Alu in Alu genome DR2
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sive in cells of squamous epithelial origin, RAI1, GPRC5A
(RAI3),  SMYD5  (RAI15),  RARRES1  and  RARRES3, and
assessed RAR binding to these elements in SCC25 cells, a
relatively well-differentiated human head and neck squa-
mous cell carcinoma (HNSCC) line [28]. SCC25 cells
express RARs and are retinoid-responsive [28], and are
arrested by RA in the G0/G1 phase of the cell cycle [29].
The genes RAI1 and GPRC5A were originally identified as
RA-regulated genes in HNSCC [30]. Similarly, SMYD5
and RARRES 1 and 3 (retinoic acid receptor responder
genes 1 and 3) were found to be induced by RA in human
keratinocytes [31]. RARRES3 expression is lost in many
tumors, and its product inhibits cell proliferation when
transiently overexpressed [32].
ChIP analysis with an anti-panRAR antibody revealed
RAR binding to all elements tested (Fig. 5), whereas no
RAR binding was observed to control sequences lacking
DR2 elements (data not shown). In most instances, bind-
ing was either not RA-dependent or weakly enhanced by
ligand, consistent with capacity of RARs to bind DNA in
the absence of ligand [15]. However, immunoprecipita-
tion of RARs associated with elements #3 in GPRC5A and
#1 in SMYD5 was consistently ligand-dependent (Fig. 5,
and data not shown). These studies are important as they
confirm that all of the Alu-DR2 elements tested are in a
chromatin environment that renders them accessible to
RARs in vivo. We also confirmed that an oligonucleotide
corresponding to the predominant DR2 element present
in Alu repeats drove robust RA-inducible gene expression
when cloned upstream of a truncated thymidine kinase
promoter (data not shown), supporting its potential to
function as an RARE in vivo.
In addition, we obtained further evidence for the function
of Alu-DR2 elements as RA-dependent enhancer
sequences from the publicly-available results of the
ENCODE Project Consortium, which mapped transcrip-
tion factor binding sites including those for RARs in 44
selected regions of the human genome (30 Mb in total)
[33]. ChIP-on-chip studies of these regions using retinoic
acid-treated human HL60 cells identified binding regions
for RARα, 17 of which encompass Alu elements contain-
ing perfect DR2 motifs (Table 3). Of these, we note that
Distribution of Alu sequences within the 10 kb flanking 5' ends of genes Figure 4
Distribution of Alu sequences within the 10 kb flanking 5' ends of genes. The 20 kb window for all genes annotated in 
the human genome were subdivided in 500 bp intervals. The number of Alu sequences and Alu sequences with a DR2 element 
were counted for each interval. Grey bars represent the ratio of the number Alu repeats within a given interval divided by the 
total number of Alu repeats within 10 kb of a gene, black bars represent the number DR2-containing Alu repeats within a given 
interval divided by the total number of Alu repeats within 10 kb of a gene, whereas black squares indicate the number Alu 
motifs with a DR2 element within a given interval divided by the total number of DR2-containing Alu repeats within 10 kb of a 
gene.
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expression of caveolin-1, the product of the CAV1 gene,
was found to be upregulated in retinoic acid-treated HL60
cells [34]. Taken together, the data of Fig. 5 and Table 3
strongly support the capacity of Alu-DR2 sequences to
function as RAREs.
Discussion
Nuclear receptor signaling, particularly that of retinoic
acid receptors, has been widely studied in animal models,
most notably the mouse. Our findings reveal striking dif-
ferences in hormone response element frequency and dis-
tribution between rodent, and primate and human
genomes. Results of the genome-wide mapping of high
affinity hormone response elements for members of the
nuclear receptor family of transcription factors presented
herein indicate that consensus DR2 retinoic acid response
elements are vastly overrepresented relative to other DR
response elements in the human genome, and are
enriched approximately 4-fold in the human genome rel-
ative to the mouse. This enrichment arose as a result of the
presence of DR2 motifs in Alu repeats, which are primate-
specific. Movement of Alu repeats and other classes of
transposable elements has been recognized as a potential
mechanism for introduction of RNA polymerase II tran-
scriptional regulatory elements for a variety of transcrip-
tion factors into promoter regions of genes [10,35,36],
thus altering the signal transduction pathways regulating
specific genes. For example, a recent study [36] used DNA-
binding profiles of representatives of different classes of
transcription factors from the TRANSFAC database [37] to
identify transcription factor binding sites in transposable
elements located in promoter regions. This study did not
screen for RAREs, for which matrices are not provided in
the TRANSFAC database.
RARs bind to Alu-DR2 motifs present in retinoic acid responsive genes in vivo Figure 5
RARs bind to Alu-DR2 motifs present in retinoic acid responsive genes in vivo. Upper panel: Schematic representa-
tion of the promoter regions of selected known retinoic acid-responsive genes containing multiple consensus DR2 RAREs 
(AGGTCAggAGTTCA) embedded within an Alu repeat sequence. Lower Panel: Results of ChIP assays for RAR binding to pro-
moter regions containing DR2 motifs. DNA from all immunoprecipitates (RAR-specific and control IgG) was amplified under 
similar conditions (40–42 cycles of PCR).
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While the presence of imperfect RAREs in Alu elements
and their capacity to function as RAREs in reporter assays
has been reported previously [17], the main findings from
our study are the unexpected large number of consensus
DR2 RAREs, and the demonstration that several of these
sites are functional RAR binding sites in vivo. It is striking
that the genome-wide number of imperfect DR2s corre-
sponding to the AGGTCAnnAGTTCG consensus, which
matches the consensus sequences of most AluS subclasses,
is not much higher (102,657) than that of the consensus
DR2s (93,278), underlining the unexpectedly high
number of perfect DR2 RAREs in the human genome (Fig.
3C). The generation of consensus DR2 elements by deam-
ination of the CpG dinucleotide within the 3' AGTTCG
motif is supported by the comparably high number of
AGGTCAnnAGTTTG sequences (80,444), which diverge
from a perfect DR2 more than the motif found in consen-
sus AluS sequences but represent the other possible site
generated by methylation/deamination at the CpG dinu-
cleotide in the B box of Alu repeats.
Demonstration that Alu DR2 RAREs are functional bind-
ing sites in their normal chromatin context is crucial given
the high frequency of methylation of Alu sequences in the
human genome [21], and the association between DNA
methylation and silencing of transcription in general, and
of Alu repeats specifically [38]. For instance, expression
and retinoic acid responsiveness of one of the genes stud-
ied above, RARRES1, is frequently inhibited in malignan-
cies by hypermethylation [39], and the extent of
methylation is inversely correlated with the state of differ-
entiation of malignant cells [40].
The capacity of Alu-DR2 motifs to function as RAREs is
supported by several lines of evidence. We identified 363
motifs within 10 kb of the 5' ends of 193 known retinoic
acid-regulated genes [see Additional file 2]. It is also note-
worthy that 8 Alu-DR2 within 10 kb of 9 genes overlap
with DNase I-hypersensitive sites from primary human
CD4+ T cells [41] [see Additional file 2]. We confirmed
the capacity of several Alu-DR2 elements to bind RARs in
vivo in retinoic acid-sensitive SCC25 cells by chromatin
immunoprecipitation analysis of receptor binding to
sequences located proximal to five genes known to be
retinoic acid-responsive in squamous carcinoma cells.
These studies indicate that access of RARs to the DR2
motifs under study was not impeded by their presence in
an Alu repeats in these cells. Moreover, our analyses of
ChIP-on-chip studies from the ENCODE consortium
showed that several Alu-DR2 elements in human HL60
cells are sites of RA-dependent recruitment of RARs (Table
3), further supporting the function of Alu-DR2 elements
as RAREs.
We found that DR2 consensus elements were present in
substantial numbers in multiple AluS subfamilies, indi-
cating that they arose throughout the course of AluS
expansion. The perfect RARE DR2 motif corresponds to
the consensus sequence in seven divergent AluS sub-
families defined by Price et al. [26], in addition to being
found sporadically throughout numerous other AluS sub-
family sequences (Additional file 4 and unpublished
results). It should be noted that the downstream half-site
of the DR2 element lies within box B of the Alu RNA
polymerase III promoter, but that the conversion of RGT-
TCG to RGTTCA to generate the consensus DR2 motif
does not necessarily impair its competence for retrotrans-
position, consistent with transcriptional activity of Alu
RNA polymerase III promoters containing RGTTCAANNC
box B motifs [25,42].
Consistent with their presence predominantly in AluS
sequences, which represent relatively ancient Alu ele-
ments, we found that the vast majority of human Alu-DR2
Table 3: Alu-DR2 elements within ENCODE ChIP-on-chip RARα binding regions.
DR2 position RARα binding region region length DR2 position in region nearest gene distance (kb)
chr11:5234577–5234590 chr11:5234153–5234769 617 437 HBG2 -2.0
chr11:116438036–116438049 chr11:116437268–116438894 1627 768 KIAA0999 36.1
chr11:5214973–5214986 chr11:5214632–5215086 455 354 HBD -2.5
chr15:41723046–41723059 chr15:41722559–41723965 1407 500 CATSPER2 5.2
chr15:41832787–41832800 chr15:41832276–41832882 607 524 PDIA3 6.9
chr15:41893221–41893234 chr15:41892245–41893398 1154 989 MFAP1 11.0
chr19:59507050–59507063 chr19:59506478–59507251 774 572 LILRA5 9.1
chr20:33783677–33783690 chr20:33783609–33783958 350 68 RBM39 (RNPC2) 9.9
chr20:33795208–33795221 chr20:33795121–33795786 666 87 RBM39 (RNPC2) -1.6
chr21:33890599–33890612 chr21:33890070–33890930 861 529 DONSON -7.7
chr21:39545848–39545861 chr21:39545687–39546093 407 161 BRWD1 61.5
chr22:30446428–30446441 chr22:30446058–30446529 472 383 C22orf30 (MGC50372) -13.1
chr6:74021882–74021895 chr6:74021526–74021987 462 369 C6orf148 7.7
chr6:108492975–108492988 chr6:108492625–108493122 498 363 OSTM1 9.6
chr7:115763054–115763067 chr7:115762699–115763680 982 368 CAV1 4.2
chr7:116952987–116953000 chr7:116952795–116953258 464 192 CTTNBP2 154.5
chrX:122568351–122568364 chrX:122567587–122568522 936 777 THOC2 -12.1BMC Genomics 2007, 8:23 http://www.biomedcentral.com/1471-2164/8/23
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motifs are present in the chimp and macaque genomes. A
few Alu-DR2 elements were apparently unique to the
human genome, although in some cases they corre-
sponded to regions that were not sequenced in the simian
genomes. While none of these uniquely human Alu-DR2s
are adjacent to known retinoid-regulated genes in
humans, it will be of interest in the future to characterize
the potential of RA to regulate their expression in appro-
priate cell model systems. It is also noteworthy that one of
these genes, CYP2A6, was shown to be regulated by the
nuclear receptor hepatic nuclear factor 4 (HNF4) [43],
which, like RARs, can recognize DR2 motifs [44].
Our previous work identified a consensus DR3 element
recognized by the VDR in vitro and in vivo in the proximal
promoter region of the cathelicidin antimicrobial peptide
gene [45], which was found to be strongly regulated by
vitamin D in a variety of human cell types. However, nei-
ther the regulation nor the response element was con-
served in mouse, and studies by others [46] showed the
DR3 to be conserved in primates, but not other species,
and present in an Alu repeat. This represents a clear exam-
ple of an Alu-driven divergence in nuclear receptor gene
regulation between primates/humans and other species.
Results presented here demonstrate that Alu repeat expan-
sion similarly has led to the generation of functional bind-
ing sites for retinoic acid receptors. Further studies of
DR2-containing Alu repeats will be necessary to deter-
mine precisely to which extent these elements have con-
tributed to the primate-specific regulation of target genes
by retinoic acid.
Conclusion
We find that consensus DR2 motifs are heavily overrepre-
sented in the human genome relative to other DR
response elements due to their presence in a subset of Alu
motifs, in particular in AluS sequences. Although DR4s
are found far less frequently in Alu repeats, those present
account for 50% of consensus DR4 motifs in the human
genome. Consensus Alu-DR2 elements arose predomi-
nantly through deamination of a methylated CpG dinu-
cleotide present in AluS elements rather than through
random base substitutions. While Alu elements can be
transcriptionally repressed by methylation-driven mecha-
nisms, our screen identified Alu-DR2 elements in pro-
moter proximal regions of numerous retinoid regulated
genes. Importantly, we found that Alu-DR2s are accessible
to RARs in vivo in two RA-responsive human cell lines,
indicating that the expansion of DR2 motifs within Alu
elements during the course of primate evolution contrib-
uted to altering regulation of gene expression by retinoic
acid.
Methods
Genome-wide identification of DR1-DR5 within Alu 
sequences
The human (hg17, May 2004) and mouse (mm6, March
2005) reference sequence chromosomes from the UCSC
Genome Browser database [47,48] were scanned for
RGKTCA motifs separated by 1 to 5 bp (DR1-DR5) using
a previously described program perl program [11,12]. The
RefSeq Genes track [49], downloaded September 21 2005,
was used to identify the DR2 located -10 to +10 kb of gene
5'-ends. A custom SQL program used the chromosomal
location of Alu sequences from the RepeatMasker track
[50] to identify included DR1-DR5. The same program
used the chromosomal location of regions bound by
RARα from the ENCODE Affy Sites track to identify DR2
elements within these regions. Another SQL program was
used to identify the DR2 in AluY that are not included
within Human/Chimp (hg17 vs panTro1) and Human/
Rhesus (hg17 vs rheMac2) pairwise BLASTZ alignment
[51]. The χ2 test to compare the distribution of Alu-DR2 to
Alu repeat was carried out with the chisq.test function of
the R statistical computing environment [52]. The cladog-
ram of AluSg subfamilies was generated with PHYLIP 3.6
[53] using the consensus of AluS families from Repbase
[54] and AluS subfamilies with RARE DR2 in their consen-
sus from Price et al [26]. All programs were run on the bio-
informatics cluster of The Quebec Bioinformatics
Network (BioneQ) and are available upon request.
ChIP assays
Approximately 2 × 107 SCC25 cells were treated for 1 h
with RA 10-6M or vehicle. Then cells were rinsed with PBS
and incubated for 10 min in PBS containing 1% formal-
dehyde at 37°C. Cells were washed with ice-cold PBS and
the cell pellets were resuspended in 300 μl of lysis buffer
(1% SDS, 10 mM EDTA, 50 mM Tris-HCl (pH 8.1) and 1×
protease inhibitor cocktail (Roche Diagnostics, Laval,
Que, Canada). Sonication was performed by pulsing three
times for 15 s to reduce DNA to fragments of ~300–500
bp in length. Centrifugation was then performed to
obtain cleared cell lysates. Lysates were diluted 1:10 in
ChIP dilution buffer (1% Triton X-100, 1 mM EDTA, 150
mM NaCl and 20 mM Tris-HCl pH 8.1). A portion of the
lysate was taken as INPUT control sample. Pre-clearing
was done by incubating the cell lysates with salmon sperm
DNA (1 μg/ml), BSA (1 μg/ml) and protein A-agarose
slurry (Santa Cruz Biotechnology, Santa Cruz CA) for 1 h.
Cell lysates were then incubated by overnight rotation at
4°C with 4 μg of either normal rabbit IgG or primary anti-
body, followed by rotation-incubation with protein A-
agarose for 2 h. The beads were rinsed three times sequen-
tially with TSE I buffer (0.1% SDS; 1% Triton X-100; 2
mM EDTA; 150 mM NaCl; 20 mM Tris-HCl, pH 8.1), TSE
II buffer (0.1% SDS; 1% Triton X-100; 2 mM EDTA; 500
mM NaCl; 20 mM Tris-HCl, pH 8.1), LiCl Wash BufferBMC Genomics 2007, 8:23 http://www.biomedcentral.com/1471-2164/8/23
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(0.25 M LiCl; 1% NP-40; 1% deoxychlolate (Na salt); 1
mM EDTA; 10 mM Tris-HCl, pH 8.1) and 2 times TE
buffer (10 mM Tris-HCl; 1 mM EDTA, pH 8.0). The beads
were eluted twice with 250 μl elution buffer (1% SDS; 0.1
M NaHCO3). To reverse the cross-linking, the eluates were
incubated in a 65°C incubator overnight and then the
samples were purified with PCR purification kit (Qiagen,
Mississauga, Ont, Canada). PCR primers used for ChIP
assays are described in Additional file 3.
List of abbreviations
ChIP, chromatin immunoprecipitation; DR, direct repeat;
HNF4, hepatic nuclear factor 4; LINEs, long interspersed
elements; RA, retinoic acid; RAR, retinoic acid receptor;
RARE, retinoic acid response element; RXR, retinoid ×
receptor; SINEs, Short INterspersed Elements; TR, thyroid
hormone receptor; VDR vitamin D receptor.
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